Articles
Latest reporting, analysis, interviews and insight from The Pharma Navigator editorial team.
-
-
Discovery & DevelopmentZealand Pharma Announces Obesity Success with Liver Disease Treatment
4 min read • 3 years ago -
Funding & InvestmentsIs Cannabis Legislation a Promising Sign for Pharmaceutical Cannabinoids?
4 min read • 3 years ago -
-
Regulatory & ComplianceAstraZeneca’s Tagrisso Receives Chemotherapy FDA Approval
4 min read • 3 years ago -
-
Manufacturing ServicesRevival in US Biotech Financing Marks End of Two-Year Slump
4 min read • 3 years ago -
-
-
Discovery & DevelopmentLantern Pharma Progresses Novel ADC Initiative in Various Solid Cancer Types
4 min read • 3 years ago -
NewsFirefly Bio Launches with $94 Million for Innovative Cancer Therapy Platform
4 min read • 3 years ago -
Join 50,000+ Pharma Professionals
Receive exclusive market analysis, biotech trends, regulatory intelligence, and executive briefings.
Advertisement here
As billionaires pour capital into age-reversal biotech, the ethical implications for public healthcare systems are.








